Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-10-01FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)
The FDA approved a supplemental application for Verapamil Hydrochloride by Teva Pharmaceuticals Inc., updating the drug’s labeling and appro…
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: Catheter Contact Force and Electrograms [Phase 4]
Phase 4 clinical trial update evaluating catheter contact force and electrograms in atrial fibrillation patients.
-
FDA approval · 2019-09-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for Verapamil Hydrochloride from Glenmark Pharmaceuticals, updating an already approved generic …
-
FDA approval · 2019-09-26FDA Approved: WARFARIN SODIUM — Supplemental Application (Exelan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Warfarin Sodium by Exelan Pharmaceuticals. This action updates the regulatory status of this…
-
FDA approval · 2019-09-25FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for verapamil hydrochloride (generic) from Nivagen Pharmaceuticals, Inc., authorizing the sale o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation [Phase 3]
Phase 3 trial comparing edoxaban to vitamin K antagonists in atrial fibrillation patients undergoing catheter ablation has completed.
-
FDA approval · 2019-09-20FDA Approved: JANTOVEN — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for JANTOVEN (warfarin sodium) submitted by Upsher-Smith Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: FIRE AND ICE Re-Ablations (Retrospective Data Collection)
A retrospective data collection update for FIRE AND ICE re-ablations in atrial fibrillation; results have been posted.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Quality of Anticoagulation With Warfarin in Patient With Atrial Fibrillation for Secondary Stroke Prevention in Korea
A completed clinical trial from Korea assessed the quality of anticoagulation with warfarin for secondary stroke prevention in patients with…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation [Phase 3]
Phase 3 trial assessing renal artery denervation in addition to catheter ablation for atrial fibrillation, completed.
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial [NA]
Clinical trial comparing catheter ablation to anti-arrhythmic drug therapy for atrial fibrillation has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) Ablation [NA]
Clinical trial update for OFDI Capsule Imaging in patients with atrial fibrillation who underwent RF ablation; study completed with results …
-
FDA approval · 2019-08-23FDA Approved: XARELTO — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for XARELTO (rivaroxaban) filed by Janssen Pharmaceuticals, resulting in labeling changes to the pro…
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Corticosteroid Pulse After Ablation [Phase 4]
A phase 4 clinical trial evaluating corticosteroid pulse therapy after ablation for atrial fibrillation has completed with results posted in…
-
FDA approval · 2019-08-15FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for amiodarone hydrochloride, granting approval for a generi…
-
FDA approval · 2019-08-14FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (Gland Pharma Limited)
The FDA approved the original abbreviated application for esmolol hydrochloride from Gland Pharma Limited, confirming a generic esmolol hydr…
-
FDA approval · 2019-08-08FDA Approved: TIKOSYN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for TIKOSYN (dofetilide) submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Patient Convenience Study (RE-SONANCE)
A completed patient convenience study (RE-SONANCE) sponsored by Boehringer Ingelheim, investigating atrial fibrillation and stroke outcomes;…
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Electrocardiogram Clinical Validation Study [NA]
Completed electrocardiogram validation study for atrial fibrillation; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: DUAL Antithrombotic Therapy in Patients With AF and ACS [Phase 4]
Clinical trial update on dual antithrombotic therapy in patients with atrial fibrillation and acute coronary syndromes (Phase 4).
-
CLINICAL_TRIALS trial_result · 2019-07-15Clinical Trial Update: Early Detection and Treatment of Esophageal Injury After Catheter Ablation for Atrial Fibrillation
A completed clinical trial studying early detection and treatment of esophageal injury after catheter ablation for atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Comparative Effectiveness and Safety Between Warfarin and Dabigatran
A completed clinical trial comparing warfarin and dabigatran for atrial fibrillation has posted results.
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: Feasibility of Perioperative Stellate Ganglion Blocks in Cardiac Surgery [NA]
A completed clinical trial evaluating the feasibility of perioperative stellate ganglion blocks in cardiac surgery for atrial fibrillation w…
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: Patient Convenience Study- NIS RELATE
Clinical trial update for the Patient Convenience Study- NIS RELATE completed with results posted in 2019, conducted in atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients [Phase 4]
Phase 4 clinical trial evaluating a pharmacogenetic-based warfarin dosing algorithm in patients with atrial fibrillation.